Update: 23.04.2024
Last week: 15 week 2024 (08.04.2024 - 15.04.2024)
Last full month: March 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 357 | -1.0% | 11.2% | 0.5 | 18 490 923 | -2.2% | 9.4% | 0.3 | -5.0% |
| MoM | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| YTD | 107 044 | 22.4% | 10.9% | 2.2 | 240 175 495 | 52.9% | 9.3% | 2.1 | -2.5% |
| MAT | 360 432 | 32.0% | 9.7% | 1.7 | 739 903 274 | 47.7% | 8.3% | 1.4 | 9.4% |
| BRAINMAX | |||||||||
| WoW | 1 171 | 1.2% | 100.0% | 0 | 4 159 472 | 0.8% | 100.0% | 0 | 1.2% |
| MoM | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| YTD | 15 254 | 55.6% | 100.0% | 0 | 54 921 593 | 65.8% | 100.0% | 0 | 55.6% |
| MAT | 52 103 | 160.7% | 100.0% | NA | 182 797 872 | 177.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 17 637 | -6.3% | 44.8% | -0.9 | 56 648 818 | -3.1% | 36.6% | -0.2 | -4.5% |
| MoM | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| YTD | 251 868 | 1.0% | 44.2% | 2 | 804 201 198 | 6.8% | 36.1% | -2.3 | -3.5% |
| MAT | 871 587 | 17.8% | 45.5% | 2.1 | 2 742 886 222 | 26.7% | 38.9% | 0.6 | 12.4% |
| MIGRENIUM | |||||||||
| WoW | 14 080 | -7.3% | 0.6% | 0 | 4 431 179 | -5.7% | 0.8% | 0 | -0.6% |
| MoM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| YTD | 184 914 | 0.6% | 0.5% | -0.1 | 53 383 974 | 61.3% | 0.7% | 0.1 | 19.9% |
| MAT | 642 645 | 8.4% | 0.5% | 0 | 142 945 810 | 32.9% | 0.5% | 0 | 16.3% |
| MODELAX-N | |||||||||
| WoW | 32 469 | -2.1% | 25.3% | 0.5 | 13 936 442 | -0.0% | 16.4% | 0.5 | -4.2% |
| MoM | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| YTD | 479 643 | 58.9% | 23.7% | 6 | 196 995 654 | 106.5% | 14.8% | 4.7 | 18.9% |
| MAT | 1 345 834 | 107.8% | 20.4% | 8.2 | 484 412 721 | 128.2% | 11.8% | 4.8 | 24.7% |
| REDUXIN | |||||||||
| WoW | 13 002 | -2.0% | 33.0% | 0.8 | 71 497 984 | -2.7% | 46.1% | -0.1 | -4.5% |
| MoM | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| YTD | 189 067 | -8.6% | 33.2% | -1.9 | 1 031 621 601 | 22.8% | 46.4% | 3.4 | -3.5% |
| MAT | 619 955 | 1.8% | 32.4% | -3.4 | 3 064 486 572 | 21.8% | 43.5% | -1 | 12.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 370 | -3.9% | 8.6% | 0.1 | 14 323 433 | -3.5% | 9.2% | -0.1 | -4.5% |
| MoM | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| YTD | 49 483 | 5.3% | 8.7% | 0.7 | 216 581 106 | 24.0% | 9.7% | 0.8 | -3.5% |
| MAT | 168 493 | 28.3% | 8.8% | 1.1 | 695 431 991 | 39.9% | 9.9% | 1.1 | 12.4% |
| SALVISAR | |||||||||
| WoW | 14 429 | 20.3% | 1.8% | 0.3 | 6 032 552 | 27.6% | 1.7% | 0.3 | 1.5% |
| MoM | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
| YTD | 147 334 | -10.0% | 1.3% | -0.2 | 56 185 586 | 6.6% | 1.1% | -0.2 | 6.3% |
| MAT | 482 044 | -19.9% | 1.2% | -0.4 | 167 215 549 | -18.4% | 1.0% | -0.4 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 107 044 | 22.4% | 10.9% | 2.2 | 240 175 495 | 52.9% | 9.3% | 2.1 | -2.5% |
| BRAINMAX | 15 254 | 55.6% | 100.0% | 0 | 54 921 593 | 65.8% | 100.0% | 0 | 55.6% |
| GOLDLINE PLUS | 251 868 | 1.0% | 44.2% | 2 | 804 201 198 | 6.8% | 36.1% | -2.3 | -3.5% |
| MIGRENIUM | 184 914 | 0.6% | 0.5% | -0.1 | 53 383 974 | 61.3% | 0.7% | 0.1 | 19.9% |
| MODELAX-N | 479 643 | 58.9% | 23.7% | 6 | 196 995 654 | 106.5% | 14.8% | 4.7 | 18.9% |
| REDUXIN CAPS | 189 067 | -8.6% | 33.2% | -1.9 | 1 031 621 601 | 22.8% | 46.4% | 3.4 | -3.5% |
| REDUXIN FORTE | 49 483 | 5.3% | 8.7% | 0.7 | 216 581 106 | 24.0% | 9.7% | 0.8 | -3.5% |
| SALVISAR | 147 334 | -10.0% | 1.3% | -0.2 | 56 185 586 | 6.6% | 1.1% | -0.2 | 6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 360 432 | 32.0% | 9.7% | 1.7 | 739 903 274 | 47.7% | 8.3% | 1.4 | 9.4% |
| BRAINMAX | 52 103 | 160.7% | 100.0% | NA | 182 797 872 | 177.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | 871 587 | 17.8% | 45.5% | 2.1 | 2 742 886 222 | 26.7% | 38.9% | 0.6 | 12.4% |
| MIGRENIUM | 642 645 | 8.4% | 0.5% | 0 | 142 945 810 | 32.9% | 0.5% | 0 | 16.3% |
| MODELAX-N | 1 345 834 | 107.8% | 20.4% | 8.2 | 484 412 721 | 128.2% | 11.8% | 4.8 | 24.7% |
| REDUXIN CAPS | 619 955 | 1.8% | 32.4% | -3.4 | 3 064 486 572 | 21.8% | 43.5% | -1 | 12.4% |
| REDUXIN FORTE | 168 493 | 28.3% | 8.8% | 1.1 | 695 431 991 | 39.9% | 9.9% | 1.1 | 12.4% |
| SALVISAR | 482 044 | -19.9% | 1.2% | -0.4 | 167 215 549 | -18.4% | 1.0% | -0.4 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 357 | -1.0% | 11.2% | 0.5 | 18 490 923 | -2.2% | 9.4% | 0.3 | -5.0% |
| BRAINMAX | 1 171 | 1.2% | 100.0% | 0 | 4 159 472 | 0.8% | 100.0% | 0 | 1.2% |
| GOLDLINE PLUS | 17 637 | -6.3% | 44.8% | -0.9 | 56 648 818 | -3.1% | 36.6% | -0.2 | -4.5% |
| MIGRENIUM | 14 080 | -7.3% | 0.6% | 0 | 4 431 179 | -5.7% | 0.8% | 0 | -0.6% |
| MODELAX-N | 32 469 | -2.1% | 25.3% | 0.5 | 13 936 442 | -0.0% | 16.4% | 0.5 | -4.2% |
| REDUXIN CAPS | 13 002 | -2.0% | 33.0% | 0.8 | 71 497 984 | -2.7% | 46.1% | -0.1 | -4.5% |
| REDUXIN FORTE | 3 370 | -3.9% | 8.6% | 0.1 | 14 323 433 | -3.5% | 9.2% | -0.1 | -4.5% |
| SALVISAR | 14 429 | 20.3% | 1.8% | 0.3 | 6 032 552 | 27.6% | 1.7% | 0.3 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| BRAINMAX | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| GOLDLINE PLUS | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| MIGRENIUM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| MODELAX-N | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| REDUXIN CAPS | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| REDUXIN FORTE | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| SALVISAR | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs